On October 27th, the National Price Bureau Directors' Meeting posted news that all drug prices will be liberalized. Drug prices are expected to usher in marketization.

　　 Blood products, drugs and contraceptives, first-class psychoactive and narcotic drugs, and patent drugs that are uniformly purchased nationwide. The prices of these four drugs are planned to be released before the end of 2014. The specific work plan for the liberalization of drug prices in the medical insurance catalogue was submitted to the State Council for approval in November 2014 and implemented in January 2015.

　　 Patented drugs are innovative drugs with a short time to market and small market sales. The price liberalization is conducive to increasing the enthusiasm for research and development and innovation.

　　The medicines in the medical insurance catalogue will be the part with the largest quantity and the greatest benefit. At present, 1,500 are under central management and 500 are under local management. According to the document, my country's pharmaceutical production and distribution environment is full of competition, and there are many types of medicines, and there are large differences in quality and cost. The current method of setting the highest retail price is unscientific and reasonable without fundamental changes in the system of "medicine for medical treatment". It is also impossible to eliminate the problem of "inflated drug prices".